XXII
CONSUMER DEFENSIVE22nd Century Group Inc
Live · NASDAQ · May 9, Close
What's Moving XXII Today?
No stock-specific AI insight has been generated for XXII yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.85
Fundamentals
Trading
XXII News
20 articles- 22nd Century Group Reports First Quarter 2026 Financial ResultsYahoo Finance·May 7, 2026
- 22nd Century Group to Announce First Quarter 2026 Results on May 7, 2026Yahoo Finance·May 4, 2026
- 22nd Century Group Shares 2026 Vision for VLN® Product Growth and Tobacco Harm Reduction LeadershipYahoo Finance·Apr 29, 2026
- 22nd Century Group Expands Reduced Nicotine Platform Through New Testing Services Agreement with North Carolina State UniversityYahoo Finance·Apr 23, 2026
- 22nd Century Advances Reduced Nicotine Product to Target Approximately Half of the ~$82 Billion U.S. Cigarette Market with 100mm VLN® Product InitiativeYahoo Finance·Apr 7, 2026
- 22nd Century Group Inc (XXII) Q4 2025 Earnings Call Highlights: Strategic Shift Fuels Growth ...Yahoo Finance·Mar 26, 2026
- 22nd Century Group Reports Fourth Quarter and Full Year 2025 Financial ResultsGlobeNewswire Inc.·Mar 26, 2026
- 22nd Century Group to Announce Fourth Quarter and Full Year 2025 Results on March 26, 2026Yahoo Finance·Mar 23, 2026
- 22nd Century Group Reports Continued Early Sales Momentum for VLN® Cigarette ProductsYahoo Finance·Feb 23, 2026
- 22nd Century Group Preliminarily Reports Fourth Quarter and Full Year 2025 Financial ResultsYahoo Finance·Feb 20, 2026
- 22nd Century CEO & Chairman Larry Firestone Provides 2025 Year-in-Review Letter to StockholdersYahoo Finance·Jan 15, 2026
- 22nd Century to Participate in the Needham Annual Growth Conference January 16, 2026Yahoo Finance·Jan 12, 2026
- 22nd Century Files VLN® MRTP Renewal – Only Combustible Tobacco Product Authorized by the FDA Specifically to Help Smokers Smoke LessYahoo Finance·Jan 6, 2026
- 22nd Century to Participate in the Emerging Growth Conference on December 10, 2025Yahoo Finance·Dec 9, 2025
- Presenting on Emerging Growth Conference 88 Day 1 on December 10; Register to live streamYahoo Finance·Dec 9, 2025
- Emerging Growth Research Releases Q3 2025 Update Report on 22nd Century GroupYahoo Finance·Nov 26, 2025
- 22nd Century Group Inc (XXII) Q3 2025 Earnings Call Highlights: Strategic Shifts and Financial ...Yahoo Finance·Nov 5, 2025
- 22nd Century: Q3 Earnings SnapshotYahoo Finance·Nov 4, 2025
- 22nd Century Group Reports Third Quarter 2025 Financial ResultsYahoo Finance·Nov 4, 2025
- 22nd Century Announces Receipt of $9.5 Million from Settlement of Insurance ClaimYahoo Finance·Oct 28, 2025
All 20 articles loaded
Price Data
52-Week Range
$0.85
Fundamentals
Trading
About 22nd Century Group Inc
22nd Century Group Inc (Ticker: XXII) is an innovative biopharmaceutical and agricultural company dedicated to tobacco harm reduction through advanced genetic engineering techniques. By focusing on the development of low-nicotine tobacco products, the firm aims to mitigate nicotine addiction while enhancing public health outcomes. As it strategically diversifies into the burgeoning hemp and cannabis markets, 22nd Century positions itself to capitalize on the expanding legal cannabis landscape. With a robust commitment to scientific research and adherence to regulatory frameworks, the company represents a compelling investment opportunity for institutional investors looking to engage in transformative sectors.